Quick answer: A NAD+ and MOTS-c blend is a laboratory research vial that combines a coenzyme (NAD+, which is not a peptide) with a mitochondrial-derived peptide (MOTS-c). The pairing is of interest in AMPK and mitochondrial research models. It is a research product only. This explainer covers each component, why they are discussed together, and what a certificate of analysis should show for both.
Two very different molecules in one vial
The NAD+ and MOTS-c blend pairs a coenzyme with a peptide, and the first thing to get straight is that they are different kinds of chemistry. NAD+ is not a peptide. Nicotinamide adenine dinucleotide is a dinucleotide: two nucleotides (one carrying nicotinamide, one carrying adenine) joined through their phosphate groups. It has no amino acid backbone and a molecular weight near 663 g/mol. MOTS-c, by contrast, is a true peptide of 16 amino acids (Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg).
The vial is coming soon to the V8 catalog as the NAD+ + MOTS-c Blend, planned at 400 mg NAD+ with 20 mg MOTS-c, for laboratory research use only. Calling it a “peptide blend” is common shorthand, but it is more accurate to call it a coenzyme-plus-peptide blend. The naming confusion is addressed in what is NAD, and is it a peptide.
NAD+ in research
NAD+ is a central redox cofactor. It shuttles electrons in glycolysis, the TCA cycle and oxidative phosphorylation, and it is also consumed as a substrate by sirtuin deacylases, PARP enzymes and CD38/CD157 NADases. Those consumption routes are why NAD+ levels are measured in studies of cellular aging models and metabolic stress. The reviews by Verdin (2015) and Covarrubias and colleagues (2021) in the references summarize this biology.
For further reading, see the NAD+ research overview, NAD+ versus NMN versus NR and NAD+ research applications. The single-compound vial is the 1000 mg NAD+ product.
MOTS-c in research
MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) belongs to the mitochondrial-derived peptides, a small group encoded inside the mitochondrial genome rather than the nuclear one. In 2015, Lee and colleagues reported that MOTS-c affected metabolic homeostasis in mouse models and in cultured cells, with involvement of the folate cycle, purine biosynthesis and activation of AMP-activated protein kinase (AMPK).
AMPK is the cell’s energy sensor. It is switched on when the AMP-to-ATP ratio rises and then shifts cells toward catabolic, ATP-producing processes. Later work in the field has also explored a reported stress-responsive movement of MOTS-c to the nucleus. Our background pages cover the AMPK pathway, nuclear translocation and what MOTS-c is, and the research overview collects primary sources. The single-compound vial is the MOTS-c product.
Why researchers think about the pair
The logic is thematic overlap, not proven synergy. NAD+ availability and AMPK activity are both tied to cellular energy status: AMPK activation is known to influence NAD+ biosynthesis and sirtuin signaling in several models, and sirtuins in turn feed back on metabolic regulators. A coenzyme supplying one side of that axis and a mitochondrial-derived peptide probing the other gives a lab a way to look at the connection in cell culture or animal models. Whether the combination behaves differently from either agent alone is an open experimental question, and any design should include single-agent controls.
NAD+ versus MOTS-c at a glance
| Property | NAD+ | MOTS-c |
|---|---|---|
| Chemical class | Dinucleotide coenzyme (not a peptide) | 16-residue peptide |
| Approximate molecular weight | About 663 g/mol | About 2.2 kDa |
| Origin | Ubiquitous cellular cofactor | Encoded in mitochondrial DNA (12S rRNA region) |
| Research themes | Redox reactions, sirtuins, PARPs, CD38 | AMPK signaling, folate and purine metabolism |
| Planned blend amount | 400 mg | 20 mg |
Reading the literature carefully
Most MOTS-c data come from a limited number of laboratories, largely in mice and cultured cells, and the field is young. NAD+ biology is better established at the level of enzymology, but results on raising NAD+ levels in whole-organism models vary with the model, the route of delivery and the readout. When you design an experiment around this blend, start from the primary papers rather than summaries, define the endpoint (for example AMPK phosphorylation, NAD+/NADH ratio or oxygen consumption) before you begin, and record the lot number of every vial used so results can be traced back to a specific certificate of analysis.
Questions a blend raises
Stability. NAD+ is a hydrolytically sensitive molecule, and the peptide has its own stability profile in solution. The two may not share the same working window after reconstitution. Compare MOTS-c storage notes with general guidance in how to reconstitute a lyophilized peptide, and use the reconstitution calculator for the arithmetic instead of estimating.
Mass ratio. A 20-to-1 mass ratio looks lopsided, but NAD+ is small and MOTS-c is larger, so the molar gap is smaller than the milligram gap suggests. NAD+ also tends to be used in much larger amounts than regulatory peptides in cell work.
Analytical method. A coenzyme and a peptide are not analyzed identically. Peptide purity methods are tuned for amino acid chains, whereas NAD+ is usually assessed with methods suited to nucleotides. A single generic purity line can hide that difference.
What to check on a blend COA
- Both components named, with NAD+ identified as a nucleotide cofactor and MOTS-c as a peptide.
- Purity data for each component, with chromatograms where available, not one combined percentage. See understanding HPLC purity, NAD+ purity testing and MOTS-c purity testing.
- Identity confirmation for each, such as a molecular weight near 663 g/mol for NAD+ and about 2.2 kDa for MOTS-c. HPLC versus mass spectrometry explains why purity and identity are separate questions.
- Per-component fill amount that matches the label, and whether it is stated as total powder or net content.
- Lot reference, test date and laboratory name matching your vial.
V8 sells its products for laboratory research use only and publishes certificates of analysis on /coa for tested lots. The general method is in how to read a COA. Browse other research compounds in the shop.
Common misunderstandings
“NAD+ is a peptide.” It is not. It has no amino acid chain.
“MOTS-c is made by the cell nucleus.” It is encoded in mitochondrial DNA, which is the defining feature of the mitochondrial-derived peptides. See MOTS-c versus other mitochondrial-derived peptides.
“Mouse results apply to people.” They do not, and this article makes no such claim.
Frequently asked questions
Is NAD+ a peptide?
No. NAD+ is a dinucleotide coenzyme with no amino acid chain. MOTS-c in the same vial is the peptide component.
What is in the NAD+ and MOTS-c blend?
A planned laboratory research vial containing 400 mg NAD+ and 20 mg MOTS-c.
Is the blend available now?
Not yet. See the product page for current status.
What is MOTS-c?
A 16-residue peptide encoded in the mitochondrial 12S rRNA region, studied in cell and animal models of metabolic signaling.
What is AMPK?
AMP-activated protein kinase, a cellular energy sensor that responds to a rising AMP-to-ATP ratio.
Why pair a coenzyme with a mitochondrial-derived peptide?
Both relate to cellular energy status, so some preclinical designs examine the NAD+ and AMPK connection. Synergy between the two is not established.
Can I run the components separately?
Yes. NAD+ and MOTS-c are also listed as single-compound vials, which allows single-agent control arms.
Why is a single purity number not enough?
A coenzyme and a peptide are analyzed with different methods, so the report should give data for each component.
Where do I find a certificate of analysis?
V8 publishes certificates of analysis on the COA page for tested lots. Match the lot number to your vial.
Is this product for human use?
No. V8 Peptides sells it for laboratory research use only, not for human or animal consumption.
References
- Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454. PMID: 25738459.
- Verdin E. NAD+ in aging, metabolism, and neurodegeneration. Science. 2015;350(6265):1208-1213. PMID: 26785480.
- Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119-141. PMID: 33353981.
All V8 Peptides products are sold for laboratory research use only. They are not drugs, foods, or cosmetics and are not intended for human or animal consumption.
